Atlas Trials

Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.

Clinical trial NCT07547384 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07547384
Sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Schizophrenia
Start date
2026-04-05
Primary completion
2027-09-05
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.